Form 4: TELA Bio, Inc. Executive Megan Smeykal Reports Stock Transactions
SEC Form 4 Filing
Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reports the disposal of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 23 and 24, 2024, Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., disposed of 423 and 539 shares of common stock, respectively, to satisfy tax withholding obligations.
- The transactions were executed at a price of $7.07 per share.
- Following these transactions, Smeykal directly owns 29,096 shares of TELA Bio, Inc. common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations, and it doesn't inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The disposal of shares by an officer could be perceived negatively by some shareholders, although it is a common practice to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/23/2024 | Disposal of 423 shares of common stock at $7.07 per share for tax withholding. |
| 02/24/2024 | Disposal of 539 shares of common stock at $7.07 per share for tax withholding. |
| 02/27/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.